An Australian company has been awarded a licence to grow medicinal cannabis in Bundaberg. An Australian medicinal cannabis company is working to address a global shortage of pharmaceutical-grade product, reducing cost and improving access at the same time. The federal Therapeutic Goods Administration’s Special Access Scheme, which authorises approved doctors to prescribe medicinal cannabis on a patient by patient basis, has been operational for just over two years in which time Australian demand has continued to grow. More than 3,100 scripts had been approved by the TGA from March 2018 to January this year but the industry has claimed that number has since risen to just under 9,000. Associate professor Dr Vicki Kotsirilos from the Royal Australian College of General Practitioners — the first authorised GP prescriber of medicinal cannabis in Australia — said national demand for medicinal cannabis was currently almost entirely supported by imported product. "The earlier […]